Smith ES, Jansen C, Miller KM, Chiang S, Alektiar KM, Hensley ML, Mueller JJ, Abu-Rustum NR, Leitao MM Jr (2022) Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma. Int J Gynecol Cancer 32(7):882–890
Article PubMed PubMed Central Google Scholar
Rajaram S, Singh L, Heda A, Chawla L, Phulware RH, Singh A, Kaur S (2024) Uterine preservation in low-grade endometrial stromal sarcoma. Gynecol Oncol Rep 1(55):101470
Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I (2003) The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecol Oncol 90(1):37–43
Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356(9233):881–887
Article PubMed CAS Google Scholar
Leiser AL, Hamid AM, Blanchard R (2004) Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor. Gynecol Oncol 94(2):567–571
Article PubMed CAS Google Scholar
Ashraf-Ganjoei T, Behtash N, Shariat M, Mosavi A (2006) Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol 4:1–5
Takehara K, Yamashita N, Motohashi T, Harano K, Nakanishi T, Tokunaga H, Susumu N, Ueda Y, Yokoyama Y, Watanabe Y, Watanabe R (2018) Prognostic factors in patients with uterine leiomyosarcoma: a multiinstitutional retrospective study from the Japanese gynecologic oncology group. Ann Oncol 1(29):viii345
De Bruyn C, Ceusters J, Vanden Brande K, Timmerman S, Froyman W, Timmerman D, Van Rompuy AS, Coosemans A, Van den Bosch T (2024) Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. Ultrasound Obstet Gynecol 63(5):683–690
Chen C, Hu YQ, Zhang XM (2017) Magnetic resonance imaging features of endometrial stromal sarcoma: a case description. Quant Imag Med Surg 7(1):159
Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S (2017) Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study. Gynecol Oncol 146(2):254–262
Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS (2008) Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 99(8):1210–1215
Article PubMed PubMed Central CAS Google Scholar
Krauss K, Bachmann C, Hartmann JT, Siegmann K, Sotlar K, Wallwiener D, Huober J (2007) Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer Res 27(5B):3477–3480
Mansi JL, Ramachandra S, Wiltshaw E, Fisher C (1990) Endometrial stromal sarcomas. Gynecol Oncol 36(1):113–118
Article PubMed CAS Google Scholar
Ryu H, Choi YS, Song IC, Yun HJ, Jo DY, Kim S, Lee HJ (2015) Long-term treatment of residual or recurrent low-grade endometrial stromal sarcoma with aromatase inhibitors: a report of two cases and a review of the literature. Oncol Lett 10(5):3310–3314
Article PubMed PubMed Central Google Scholar
Nakayama K, Ishikawa M, Nagai Y, Yaegashi N, Aoki Y, Miyazaki K (2010) Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate. Int J Clin Oncol 15:179–183
Article PubMed CAS Google Scholar
Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, Martin A, Breau JL (2003) Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 20:87–93
Comments (0)